Showing results (51-60 of 146) with videos related to
Sort By:
Pageof 15
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 16, 1998
Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and deathJ M Raboud, J Singer, A Thorne, et al.Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
Successful simplification of HAART in patients with acute primary HIV infectionA Sinicco, S Bonora, I Arnaudo, et al.Archives of Internal Medicine|April 14, 1997
Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. The Gruppo Italiano di Studio Tubercolosi e AIDSE Girardi, G Antonucci, G Ippolito, et al.The Journal of Antimicrobial Chemotherapy|February 14, 1998
Comparison of dose doubling with probenecid for sustaining serum cefuroxime levelsA M Garton, R P Rennie, J Gilpin, et al.HIV Medicine|June 15, 2007
Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccineS D Shafran, L D Mashinter, A Lindemulder, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1992
Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infectionsM Cruciani, A Navarra, G Di Perri, et al.JAMA|July 3, 1996
Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study GroupS L Sacks, F Y Aoki, F Diaz-Mitoma, et al.Clinical EEG (Electroencephalography)|January 1, 1989
Electroencephalography in the early diagnosis of HIV-related subacute encephalitis: analysis of 185 patientsA Parisi, M Strosselli, G Di Perri, et al.Lancet (London, England)|September 2, 1995
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individualsS Vento, L Guella, F Mirandola, et al.Lancet (London, England)|January 13, 1996
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virusS Vento, F Cainelli, F Mirandola, et al.Pageof 15